Bone Biologics (BBLG) Total Debt (2010 - 2019)

Bone Biologics (BBLG) has 10 years of Total Debt data on file, last reported at $11.3 million in Q4 2019.

• Total Debt for Q4 2019 came in at $11.3 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $11.3 million (changed N/A YoY), and the FY2019 annual result was $11.3 million, changed N/A from the prior year.
• Total Debt advanced to $11.3 million in Q4 2019 per BBLG's latest filing, from $9.0 million in the prior quarter.
• Over five years, Total Debt peaked at $20.1 million in Q3 2017 and troughed at $3.8 million in Q1 2015.
• A 5-year average of $11.9 million and a median of $10.8 million in 2015 frame the typical range for Total Debt.
• The sharpest annual moves came in 2015 and 2018: Total Debt soared 8776.19% in 2015, then tumbled 55.34% in 2018.
• A 5-year view of Total Debt shows it stood at $7.1 million in 2015, then rose by 23.72% to $8.8 million in 2016, then fell by 6.09% to $8.2 million in 2017, then advanced by 9.36% to $9.0 million in 2018, then grew by 25.78% to $11.3 million in 2019.
• Business Quant data shows BBLG's Total Debt at $11.3 million in Q4 2019, $9.0 million in Q3 2018, and $8.6 million in Q2 2018.